News

The Sept. 6 hybrid public meeting, hosted by the Reagan-Udall Foundation for the FDA, drew experts, advocates and critics to discuss how to move forward advancing PTSD treatment. While the official agenda skirted the recent MDMA decision, public…

In the spring, the Reagan-Udall Foundation for the FDA held a series of roundtable discussions with invited stakeholders. These conversations focused on the Food Safety Modernization Act’s Requirements for Additional Traceability Records for Certain…

The Reagan-Udall Foundation for the Food and Drug Administration is a nonprofit organization that was created by Congress to advance the mission of the FDA. The Foundation held a meeting recently entitled “Advancing Treatments for Post-Traumatic Stress…

The discussion, hosted by the Reagan-Udall Foundation for the Food and Drug Administration, a nonprofit formed by Congress to support FDA, didn’t focus specifically on psychedelic-assisted therapies, but the topic nevertheless featured prominently—…

On September 6, the Reagan-Udall Foundation for the Food and Drug Administration, an independent nonprofit created by Congress in 2007 to support the FDA’s mission, hosted a public meeting in Washington, DC, to discuss the latest advancements in post-…

Reagan Udall Foundation for the US Food and Drug Administration (FDA), a non-profit organization created by Congress, hosted the hybrid public meeting “Advancing Treatments for Post-Traumatic Stress Disorder” on September 6, 2024.

On Wednesday, the FDA issued a Constituent Update detailing efforts to enhance food traceability. Deputy Commissioner Jim Jones highlighted the FDA’s online resources regarding the Food Traceability Rule, as well as roundtables with the Reagan-Udall…

FMI – The Food Industry Association has expressed its support for the process set forth by the U.S. Food and Drug Administration (FDA) and the nonprofit Reagan-Udall Foundation to solicit feedback from stakeholders about the challenges involved in…

Subsequently, the Reagan-Udall Foundation was contracted by the FDA to conduct a series of three invitation-only industry stakeholder meetings focused on FSMA 204 implementation challenges. IFPA attended all of these.

“This is like the weight-loss clinic,” Jenni Wai, Ohio’s chief pharmacist, said of ketamine providers at a June workshop held by the Reagan-Udall Foundation, a congressionally created nonprofit that advises the FDA. “This is like the med spas and the…